Raxibacumab
- Product NDC
- 49401-103
- 11-digit product format
- 494010103
- Labeler code
- 49401
- Product ID
- 49401-103_7ca23f5f-4c47-4280-a2e8-433b69e1f5cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- raxibacumab
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Human Genome Sciences, Inc.
- Application
- BLA125349
- Marketing category
- BLA
- Marketing start
- 2012-12-14
- Marketing end
- 2022-05-31
- Substance
- RAXIBACUMAB
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Anthrax Protective Antigen-directed Antibody [EPC],Anthrax Protective Antigen-directed Antibody Interactions [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49401-103-01 | 49401010301 | 1 VIAL, SINGLE-USE in 1 CARTON (49401-103-01) > 34 mL in 1 VIAL, SINGLE-USE | 2012-12-14 | 2022-05-31 | No | No | Current |